COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits

NeuroImage

Volumn 32, Issue 4, 2006, Pages 1722-1732

  Winterer, Georg ^a,b   Musso, Francesco ^a,b   Vucurevic, Goran ^b   Stoeter, Peter ^b   Konrad, Andreas ^b   Seker, Berna ^b   Gallinat, Juergen ^c   Dahmen, Norbert ^b   Weinberger, Daniel R ^d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Attention; COMT; Dopamine; fMRI; Prefrontal

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; METHIONINE; VALINE;

ADULT; ARTICLE; BLOOD OXYGENATION; BLOOD OXYGENATION LEVEL DEPENDENT; BRAIN MICROCIRCULATION; CALCULATION; CATECHOL METHYLTRANFERASE GENE; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; FEMALE; GENE; HEAD MOVEMENT; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INTELLIGENCE QUOTIENT; MALE; NEUROIMAGING; NORMAL HUMAN; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REACTION TIME; SIGNAL NOISE RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; VISUAL STIMULATION;

ADULT; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; PHOTIC STIMULATION; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33748294193     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.05.058     Document Type: Article

References (80)

1. Amit D.J., and Brunel N. Model of global spontaneous activity and local structured activity during delay periods in the cerebral cortex. Cereb. Cortex 7 (1997) 237-252
2. Apud, J.A., Mattay, V., Chen, J., Kolachana, B.S., Egan, M.F., Goldberg, T.E., Weinberger, D.R., in press. Comparison of the effects of Tolcapone and Entacapone on cognition and fMRI in normal volunteers. Arch. Gen. Psychiatry.
3. Baker K., Baldeweg T., Sivagnanasundaram S., Scambler P., and Skuse D. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol. Psychiatry 58 (2005) 23-31
4. Bearden C.E., Jawad A.F., Lynch D.R., Sokol S., Kanes S.J., McDonald-McGinn D.M., Saitta S.C., Harris S.E., Moss E., Wang P.P., Zackai E., Emanuel B.S., and Simon T.J. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am. J. Psychiatry 161 (2004) 1700-1702
5. Behrens T., Woolrich M.W., and Smith S. Multi-Subject Null Hypothesis Testing Using a Fully Bayesian Framework: Theory (2003), Human Brain Mapping Meeting, New York City
6. Bertolino A., Caforio G., Blasi G., De Candia M., Latorre V., Petruzzella V., Altamura M., Nappi G., Papa S., Callicott J.H., Mattay V.S., Bellomo A., Scarabino T., Weinberger D.R., and Nardini M. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am. J. Psychiatry 161 (2004) 1798-1805
7. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., Goldman R.S., Hoptman M.J., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., Kunz M., Chakos M., Cooper T.B., and Lieberman J.A. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol. Psychiatry 52 (2002) 701-707
8. Blasi G., Mattay V.S., Bertolino A., Elvevag B., Callicott J.H., Das S., Kolachana B.S., Egan M.F., Goldberg T.E., and Weinberger D.R. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J. Neurosci. 25 (2004) 5038-5045
9. Bruder G.E., Keilp J.G., Xu H., Shikhman M., Schori E., Gorman J.M., and Gilliam T.C. Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol. Pschyiatry 58 (2005) 901-907
10. Buckner R.L., Goodman J., Burock M., Rotte M., Koutstaal W., Schacter D.L., Rosen B.R., and Dale A. Functional-anatomic correlates of subject priming in humans revealed by rapid presentation event-related fMRI. Neuron 20 (1998) 285-296
11. Chen J.C., Galpern W.R., Brownell A.L., Matthews R.T., Bogdanov M., Isacon O., Keltner J.R., Beal M.F., Rosen B.R., and Jenkins B.G. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn. Reson. Med. 38 (1997) 389-398
12. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.K., Apud J., Egan M.F., Kleinman J.E., and Weinberger D.R. Functional analysis of genetic variation in COMT: effects on mRNA, protein and enzyme activity in postmortem brain. Am. J. Hum. Genet. 75 (2004) 807-821
13. Cools R., Stefanova E., Barker R.A., Robbins T.W., and Owen A.M. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex. Brain 125 (2002) 584-594
14. Daniel D.G., Berman K.F., and Weinberger D.R. The effect of apomorphine on regional cerebral blood flow in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 1 (1989) 377-384
15. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Coppola R., Handel S., Bigelow L.B., Goldberg T.E., Berman K.F., and Kleinman J.E. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J. Neurosci. 11 (1991) 1907-1917
16. De Frias C.M., Annerbrink K., Westberg L., Erikkson E., Adolfsson R., and Nilsson L.G. Catechol-O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J. Cogn. Neurosci. 17 (2005) 1018-1025
17. Diamond A., Briand L., Fossella J., and Gehlbach L. Genetic and neurochemical modulation of prefrontal functions in children. Am. J. Psychiatry 161 (2004) 125-132
18. Durstewitz D., and Seamans J.K. The computational role of dopamine D1 receptors in working memory. Neural Netw. 15 (2002) 561-572
19. Durstewitz D., Seamans J.K., and Sejnowski T.J. A neurocomputational theory of the dopaminergic modulation of working memory functions. J. Neurosci. 19 (1999) 2807-2822
20. Durstewitz D., Seamans J.K., and Sejnowski T.J. Neurocomputational models of working memory. Nat. Neurosci. 3 (2000) 1184-1191 (Suppl.)
21. 108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6917-6922
22. Enoch M.A., Xu K., Ferro E., Harris C.R., and Goldman D. Genetic origins of anxiety in women: a role for functional catechol-O-methyltransferase polymorphism. Psychiatr. Genet. 13 (2003) 33-41
23. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. The Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-1) (1995), New York State, New York
24. Foltynie T., Goldberg T.E., Lewis S.G., Blackwell A.D., Kolachana B.S., Weinberger D.R., Robbins T.W., and Barker T.A. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Mov. Disord. 19 (2004) 885-891
25. Forman S.D., Cohen J.D., Fitzgerald M., Eddy W.F., Mintun M.A., and Noll D.C. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn. Reson. Med. 33 (1995) 636-647
26. Friston K.J., Worsley K.J., Frakowiak R.S.J., Mazziotta J.C., and Evans A.C. Assessing the significance of focal activations using their spatial extent. Hum. Brain Mapp. 1 (1994) 214-220
27. Galderisi S., Maj M., Kirkpatrick B., Piccardi P., Mucci A., Invernizzi G., Rossi A., Pini S., Vita A., Cassano P., Stratta P., Severino G., and Del Zompo M. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment. Neuropsychobiology 52 (2005) 83-89
28. Gallinat J., Mulert C., Bajbouj M., Rentzsch J., Senkowski D., Schunter J., Muchtieva R., Kronfeldt D., Nisslé S., Herrmann W.M., and Winterer G. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. NeuroImage 17 (2002) 110-127
29. Gallinat J., Bajbouj M., Sander T., Schlattmann P., Xu K., Ferro E.F., Goldman D., and Winterer G. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol. Psychiatry 54 (2003) 40-48
30. Gasparini M., Fabrizio E., Bonifati V., and Meco G. Cognitive improvement during Tolcapone treatment in Parkinson's disease. J. Neural Transm. 104 (1997) 887-894
31. Glatt S.J., Faraone S.V., and Tsuang M.T. Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am. J. Psychiatry 160 (2003) 469-476
32. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., and Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9991-9996
33. 158Met genotype in schizophrenia. Arch. Gen. Psychiatry 60 (2003) 889-896
34. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 14 (1995) 477-485
35. Gorelova N.A., and Yang C.R. Dopamine D1/D5 receptor activation modulates a persistent current in rat prefrontal cortical neurons in vitro. J. Neurophysiol. 84 (2000) 75-87
36. Grasby P.M., Frith C.D., Friston K.J., Simpson J., Fletcher P.C., Frackowiak R.S.J., and Dolan R.J. A graded task approach to the functional mapping of brain areas implicated in auditory-verbal memory. Brain 117 (1994) 1271-1282
37. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
38. Jenkinson M., Bannister P., Brady J., and Smith S. Improved optimisation for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17 (2002) 825-841
39. Khromova I., Voronina T., Kraineva V.A., Zolotov N., and Mannisto P.T. Effects of catechol-o-methyltransferase inhibitors on single trial passive avoidance retention in rats. Behav. Brain Res. 86 (1997) 49-57
40. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
41. Liljequist R., Haapalinna A., Ahlander M., Li Y.H., and Mannisto P.T. Catechol-o-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav. Brain Res. 82 (1997) 195-202
42. Logothetis N.K., Pauls J., Augath M., Trinath T., and Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature 412 (2001) 150-157
43. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., and Taskinen J. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
44. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., and Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry 159 (2002) 652-654
45. Mattay V.S., Berman K.F., Ostrem J.L., Esposito G., Van Horn J.D., Bigelow L.B., and Weinberger D.R. Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J. Neurosci. 16 (1996) 4816-4822
46. Mattay V.S., Tessitore A., Callicott J.H., Bertolino A., Goldberg T.E., Chase T.N., Hyde T.M., and Weinberger D.R. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann. Neurol. 51 (2002) 156-164
47. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., Kolachana B., Callicott J.H., and Weinberger D.R. Catechol-O-methyltransferase val158met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6186-6191
48. Maurice N., Tkatch T., Meisler M., Sprunger L.K., and Surmeier D.J. D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. J. Neurosci. 21 (2001) 2268-2277
49. Meyer-Lindenberg A., Kohn P.D., Kolachana B., Kippenhan S., McInerney-Leo A., Nussbaum R., Weinberger D.R., and Berman K.F. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat. Neurosci. 8 (2005) 594-596
50. Mulert C., Gallinat J., Pascual-Marqui R., Dorn H., Frick K., Schlattmann P., Mientus S., Herrmann W.M., and Winterer G. Reduced event-related current density in the anterior cingulate cortex in schizophrenia. NeuroImage 13 (2001) 589-600
51. Musso F., Konrad A., Vucurevic G., Schäffner C., Friedrich B., Frech P., Stoeter P., and Winterer G. Distributed BOLD response in association cortex vector state space predicts reaction time during selective attention. NeuroImage 29 (2006) 1311-1318
52. Rao S.G., Williams G.V., and Goldman-Rakic P.S. Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC. J. Neurophysiol. 81 (1999) 1903-1916
53. Rosa A., Peralta V., Cuesta M.J., Zarzuela A., Serrano F., Martinez-Larrea A., and Fananas L. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am. J. Psychiatry 161 (2004) 1110-1112
54. Sawaguchi T., Matsumura M., and Kubota K. Dopamine modulates neuronal activities related to motor performance in the monkey prefrontal cortex. Brain Res. 371 (1986) 404-408
55. Sawaguchi T., Matsumura M., and Kubota K. Catecholaminergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex. J. Neurophysiol. 63 (1990) 1385-1400
56. Seamans J.K., and Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 74 (2003) 1-58
57. Seamans J.K., Durstewitz D., Christie B.R., Stevens C.F., and Sejnowski T.J. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 301-306
58. Seamans J.K., Gorelova N., Durstewitz D., and Yang C.R. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J. Neurosci. 21 (2001) 3628-3638
59. Smith S. Fast robust automated brain extraction. Hum. Brain Mapp. 17 (2002) 143-155
60. Smolka M.N., Schumann G., Wrase J., Grusser S.M., Flor H., Mann K., Braus D.F., Goldmann D., Buchel C., and Heinz A. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J. Neurosci. 25 (2005) 836-842
61. Stefanis N.C., van Os J., Avramopoulos D., Smynis N., Evdokimidis I., and Stefanis C.N. Effect of COMT Val158Met polymorphism on the continuous performance test, identical pair version: tuning rather than improving performance. Am. J. Psychiatry 162 (2005) 1752-1754
62. Turnbridge E.M., Bannerman D.M., Sharp T., and Harrison P.J. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J. Neurosci. 24 (2004) 5331-5335
63. Wang J., and O'Donnell P. D(1) dopamine receptors potentiate NMDA-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. Cereb. Cortex 11 (2001) 452-462
64. Weickert T.W., Goldberg T.E., Mishara A., Apud J.A., Kolachana B.S., Egan M.F., and Weinberger D.R. Catechol-O-methyltransferase val158met genotype predicts working memory response to antipsychotic medications. Biol. Psychiatry 56 (2004) 677-682
65. Weinberger D.R., Berman K.F., and Chase T.N. Mesocortical dopamine and human cognition. Ann. N. Y. Acad. Sci. 537 (1988) 330-338
66. Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., Berman K.F., and Goldberg T.E. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry 50 (2001) 825-844
67. Weinshilboum R.M., Otterness D.M., and Szumlanski C.L. Methylation pharmacogenetics: catechol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 19-52
68. Williams G.V., and Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376 (1995) 572-575
69. Williams H.J., Glaser B., Williams N.M., Norton N., Zammit S., MacGregor S., Kirvov G.K., Owen M.J., and O'Donovan M.C. No association between schizophrenia and polymorphisms in COMT in two large samples. Am. J. Psychiatry 162 (2005) 1736-1738
70. Winterer G., and Goldman D. Genetics of human prefrontal function. Brain Res. Brain Res. Rev. 43 (2003) 134-163
71. Winterer G., and Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27 (2004) 683-690
72. Winterer G., Ziller M., Dorn H., Frick K., Mulert C., Wuebben Y., Herrmann W.M., and Coppola R. Schizophrenia: reduced signal-to-noise ratio and impaired phase-locking during information processing. Clin. Neurophysiol. 111 (2000) 837-849
73. Winterer G., Mulert C., Mientus S., Gallinat J., Schlattmann P., Dorn H., and Herrmann W.M. P300 and LORETA: comparison of normal subjects and schizophrenic patients. Brain Topogr. 13 (2001) 299-313
74. Winterer G., Adams C.A., Jones D.W., and Knutson B. Volition to action-An event-related fMRI study. NeuroImage 17 (2002) 851-858
75. Winterer G., Egan M.F., Goldberg T.E., Coppola R., and Weinberger DR. P300 and genetic risk for schizophrenia. Arch. Gen. Psychiatry 60 (2003) 158-1167
76. Winterer G., Coppola R., Goldberg T.E., Egan M.F., Jones D.W., Sanchez C.E., and Weinberger D.R. Prefrontal broadband noise, working memory and genetic risk for schizophrenia. Am. J. Psychiatry 161 (2004) 490-500
77. Winterer G., Egan M.F., Kolachana B.S., Goldberg T.E., Coppola R., and Weinberger D.R. Prefrontal electrophysiologic 'noise' and COMT genotype in schizophrenia. Biol. Psychiatry (2006) (Electronic publication ahead of print)
78. Winterer, G., Musso, F., Beckmann, C., Mattay, V., Egan, M.F., Jones, D.W., Callicott, J.H., Coppola, R., Weinberger, D.R., in press. Instability of prefrontal signal processing in schizophrenia. Am. J. Psychiatry.
79. Worsley K.J., Evans A.C., Marrett S., and Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J. Cereb. Blood Flow Metab. 12 (1992) 900-918
80. Yang C.R., and Seamans J.K. Dopamine D1 receptor actions in layer V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J. Neurosci. 16 (1996) 1922-1935